Cynata Announces Ethics Approval and Expedited Regulatory Pathway for Phase 3 Osteoarthritis Clinical Trial
18 June 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to report important progress towards the commencement of recruitment in the Phase 3 clinical trial of CYP-004, its CymerusTM mesenchymal stem cell…
Medtronic Self-Expanding Venous Stent Demonstrates Favorable Outcomes in Patients with Venous Outflow Obstruction
16 June 2020 Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre™ venous self-expanding stent system in subjects with…
Global Expansion Continues: Sienna enters Greek market with hTERT IVD
19 June 2020 Aenorasis S.A. appointed exclusive distributor in Greece and Cyprus Aenorasis has net annual turnover of €34.9 million and was awarded the Boussias Communications Golden Distinction Healthcare Business Award in Greece (2019) Bladder cancer is globally…
Monash University Announces Research Collaboration With Janssen To Tackle Coeliac Disease
17 June 2020 Monash University has signed a multi-year research collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to advance the understanding of the immune mechanisms underpinning Coeliac Disease and inform…
COVID-19 Impact On The MTP Sector – New Reports Launched
18 June 2020 To better understand the burden of the COVID-19 lockdown on the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia, MTPConnect recently undertook research, in partnership with L.E.K. Consulting, to explore the impacts of the…
BioCurate and Uniseed sign early stage research commercialisation agreement
17 June 2020 Melbourne – BioCurate, an independently-operated joint venture between the University of Melbourne and Monash University, has entered into an agreement with leading Australian commercialisation fund Uniseed to collaborate on projects of specific interest and facilitate…
Sienna appoints Triolab exclusive distributor in Sweden
2 June 2020 • Triolab AB appointed exclusive distributor in Sweden for Sienna’s hTERT test as well as future products in the portfolio • Triolab AB is a subsidiary of AddLife AB (ALIF-B: STO) a Swedish-based healthcare company…
Trial seeking kids allergic to egg to test pioneering allergy treatment
12 June 2020 A trial led by the Murdoch Children’s Research Institute (MCRI) is recruiting 80 children and adolescents allergic to egg to test a pioneering new approach to food allergies. MCRI Professor Mimi Tang is developing a probiotic and peanut immunotherapy…
CSL to Acquire Biotech Company Vitaeris
9 June 2020 CSL Limited announced that it has agreed to exercise its right to acquire Vitaeris Inc., a clinical-stage biotechnology company focused on the phase III development of a treatment for rejection in solid organ kidney transplant…
AdAlta Receives Approval to Commence Phase 1 Clinical Trial of AD-214
10 June 2020 Highlights Human Research Ethics Committee approves Phase I human clinical trial of AD-214 No further regulatory review required First healthy volunteer subject expected to receive AD-214 in late July Top-line safety results from healthy volunteer…
NASA’s JPL selects Planet Innovation to manufacture ventilator in Australia
9 June 2020 NASA’s Jet Propulsion Laboratory has selected Planet Innovation as the only Australian manufacturer of a new ventilator tailored for COVID-19 patients. PI is among 13 international companies and eight U.S. manufacturers selected from more than…
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
5 June 2020 • CSL appointed Trusted Manufacturer for University of Queensland’s “molecular clamp” enabled COVID-19 vaccine candidate • CEPI and CSL will share costs associated with the clinical development and manufacture of the vaccine candidate • A…
